FR2419722A1 - Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus - Google Patents

Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus

Info

Publication number
FR2419722A1
FR2419722A1 FR7900916A FR7900916A FR2419722A1 FR 2419722 A1 FR2419722 A1 FR 2419722A1 FR 7900916 A FR7900916 A FR 7900916A FR 7900916 A FR7900916 A FR 7900916A FR 2419722 A1 FR2419722 A1 FR 2419722A1
Authority
FR
France
Prior art keywords
entero
sugar
coated
gastro
cores
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7900916A
Other languages
English (en)
French (fr)
Other versions
FR2419722B1 (enExample
Inventor
Gilberto Dondi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer SpA
Original Assignee
Bayer Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Italia SpA filed Critical Bayer Italia SpA
Publication of FR2419722A1 publication Critical patent/FR2419722A1/fr
Application granted granted Critical
Publication of FR2419722B1 publication Critical patent/FR2419722B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR7900916A 1978-03-13 1979-01-15 Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus Granted FR2419722A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21193/78A IT1115596B (it) 1978-03-13 1978-03-13 Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo

Publications (2)

Publication Number Publication Date
FR2419722A1 true FR2419722A1 (fr) 1979-10-12
FR2419722B1 FR2419722B1 (enExample) 1981-07-31

Family

ID=11178168

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7900916A Granted FR2419722A1 (fr) 1978-03-13 1979-01-15 Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus

Country Status (3)

Country Link
ES (1) ES477354A1 (enExample)
FR (1) FR2419722A1 (enExample)
IT (1) IT1115596B (enExample)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817A1 (fr) * 1981-03-11 1982-09-15 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
EP0080341A3 (en) * 1981-11-20 1983-09-14 A/S Alfred Benzon Pharmaceutical multiple-units formulation
EP0092060A1 (en) * 1982-04-15 1983-10-26 LABORATORI PROPHIN Industria Chimica Farmaceutica S.p.A. Pharmaceutical products in sustained-release form, and their preparation process
EP0202051A3 (en) * 1985-05-06 1987-08-19 American Home Products Corporation Therapeutic compositions for oral administration
EP0396425A3 (en) * 1989-05-05 1992-11-19 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5356625A (en) * 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
US5597564A (en) * 1986-08-28 1997-01-28 Enzacor Properties Limited Method of administering a microgranular preparation to the intestinal region of animals
WO1998016206A1 (en) * 1996-10-11 1998-04-23 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
WO1998022096A1 (en) * 1996-11-15 1998-05-28 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US7829122B2 (en) 2000-11-16 2010-11-09 Ethypharm Microgranules based on active principle and method for making same
US8603520B2 (en) 2003-06-26 2013-12-10 Intellipharmaceutics Corp. Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US9078827B2 (en) 2006-05-12 2015-07-14 Isa Odidi Pharmaceutical composition having reduced abuse potential
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE106242T1 (de) * 1986-08-28 1994-06-15 Enzacor Pty Ltd Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren.
WO1988001512A1 (en) * 1986-08-28 1988-03-10 Thomas Ko Sai Ying Animal growth promotant
JP5457830B2 (ja) 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1140400A (en) * 1966-05-16 1969-01-15 Hoffmann La Roche Therapeutic compositions and a process for the manufacture thereof
LU64542A1 (enExample) * 1971-11-23 1972-06-20
FR2157847A1 (enExample) * 1971-10-12 1973-06-08 Lilly Co Eli
LU72439A1 (enExample) * 1975-05-09 1977-02-09

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1140400A (en) * 1966-05-16 1969-01-15 Hoffmann La Roche Therapeutic compositions and a process for the manufacture thereof
FR2157847A1 (enExample) * 1971-10-12 1973-06-08 Lilly Co Eli
LU64542A1 (enExample) * 1971-11-23 1972-06-20
LU72439A1 (enExample) * 1975-05-09 1977-02-09

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817A1 (fr) * 1981-03-11 1982-09-15 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
EP0080341A3 (en) * 1981-11-20 1983-09-14 A/S Alfred Benzon Pharmaceutical multiple-units formulation
EP0092060A1 (en) * 1982-04-15 1983-10-26 LABORATORI PROPHIN Industria Chimica Farmaceutica S.p.A. Pharmaceutical products in sustained-release form, and their preparation process
EP0202051A3 (en) * 1985-05-06 1987-08-19 American Home Products Corporation Therapeutic compositions for oral administration
US5356625A (en) * 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
US5597564A (en) * 1986-08-28 1997-01-28 Enzacor Properties Limited Method of administering a microgranular preparation to the intestinal region of animals
EP0396425A3 (en) * 1989-05-05 1992-11-19 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
WO1998016206A1 (en) * 1996-10-11 1998-04-23 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
WO1998022096A1 (en) * 1996-11-15 1998-05-28 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US7829122B2 (en) 2000-11-16 2010-11-09 Ethypharm Microgranules based on active principle and method for making same
US8603520B2 (en) 2003-06-26 2013-12-10 Intellipharmaceutics Corp. Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US9636306B2 (en) 2003-06-26 2017-05-02 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9078827B2 (en) 2006-05-12 2015-07-14 Isa Odidi Pharmaceutical composition having reduced abuse potential
US10632205B2 (en) 2006-05-12 2020-04-28 Intellipharmaceutics Corp Pharmaceutical composition having reduced abuse potential
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition

Also Published As

Publication number Publication date
ES477354A1 (es) 1980-03-01
FR2419722B1 (enExample) 1981-07-31
IT7821193A0 (it) 1978-03-13
IT1115596B (it) 1986-02-03

Similar Documents

Publication Publication Date Title
FR2419722A1 (fr) Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus
JPS5664788A (en) Method for imparting enzyme activity to solid surface
ATE20518T1 (de) Trockene pulverige allergenzusammensetzung und verfahren zu deren herstellung.
ZA792283B (en) Structural analogs of natural glycerides,process for their preparation and pharmaceutical compositions thereof
ES466033A1 (es) Procedimiento para la preparacion de particulas de percarbo-nato sodico
CN104027311A (zh) 一种含有富马酸二甲酯的肠溶缓释微丸
IL66605A0 (en) Slow release composite pesticide granules and methods for their preparation and use
JPS5237700A (en) Treating system of radioactive waste fluid by zeolite
JPS5245597A (en) Ultraviolet rays curing accelerator
JPS5223140A (en) Method for the simultaneous coating of both sides of plates
JPS5279030A (en) Cosmetics
JPS525738A (en) Process for racemization of optically active 2,2-dimethyl-3-(2,2-dichl orovinyl)-cyclopropanecarboxylic acid and its derivatives
JPS5227966A (en) Tilting type disk brake
JPS5244285A (en) Method of treating microbial cells containing glucose isomerase
DE3166825D1 (en) Process for manufacture of a coated acetylsalicylic-acid formulation
JPS5247883A (en) Preparation of molded product of hydrogel
JPS52151788A (en) Method of preparation immobilized enzyme or microbial cellresin composite
JPS5250283A (en) Automatic revolution balance correcting device
GB2014576B (en) Thieno 3,2c and thieno 2,3 c pyridines process for their preparation and therapeutic composition containing them
JPS51125339A (en) Optically and biologically active meth acyloxyyalphaa **methylamino*methyl**benzyll alcohol and process for preparation thereof
JPS522065A (en) Method of drying caprolactam waste liquid through atomization
ES464642A1 (es) Procedimiento para la preparacion de formas de preparados deacido 3-n-pirrolidino-4-fenoxi-5-sulfamibenzoico.
JPS5229564A (en) Manufacturing process of elastic clasp
Dangelmaier et al. Trend-setting simulation system for materials flow and warehousing processes.
JPS5261600A (en) Method of distributing stream in rearing ponds

Legal Events

Date Code Title Description
ST Notification of lapse